Business Description
Sequana Medical NV
ISIN : BE0974340722
Compare
Compare
Traded in other countries / regions
SEQUA.Belgium2SE.GermanySEQUAb.UKSQNMF.USA IPO Date
2019-10-28Description
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | -1.81 | |||||
| Debt-to-Equity | -1.14 | |||||
| Debt-to-EBITDA | -1.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -39.11 | |||||
| Beneish M-Score | -3.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.6 | |||||
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | 0.8 | |||||
| 3-Year FCF Growth Rate | 0.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 51.64 | |||||
| Future 3-5Y Total Revenue Growth Rate | 287.09 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.41 | |||||
| Quick Ratio | 0.29 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 8398.54 | |||||
| Days Sales Outstanding | 75.41 | |||||
| Days Payable | 8584 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.4 | |||||
| Shareholder Yield % | -36.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.27 | |||||
| Operating Margin % | -5308.99 | |||||
| Net Margin % | -6262.67 | |||||
| FCF Margin % | -5925.12 | |||||
| ROA % | -177.2 | |||||
| ROIC % | -143.54 | |||||
| ROC (Joel Greenblatt) % | -1036.46 | |||||
| ROCE % | -3982.54 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 57.33 | |||||
| EV-to-EBIT | -2.17 | |||||
| EV-to-EBITDA | -2.24 | |||||
| EV-to-Revenue | 112.33 | |||||
| EV-to-FCF | -2.19 | |||||
| Earnings Yield (Greenblatt) % | -46.08 | |||||
| FCF Yield % | -84.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sequana Medical NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.434 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 6.16 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 6.16 - 6.16 | ||
| Shares Outstanding (Mil) | 44.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sequana Medical NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sequana Medical NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sequana Medical NV Frequently Asked Questions
What is Sequana Medical NV(CHIX:SEQUAb)'s stock price today?
The current price of CHIX:SEQUAb is €6.16. The 52 week high of CHIX:SEQUAb is €6.16 and 52 week low is €6.16.
When is next earnings date of Sequana Medical NV(CHIX:SEQUAb)?
The next earnings date of Sequana Medical NV(CHIX:SEQUAb) is 2025-03-28 Est..
Does Sequana Medical NV(CHIX:SEQUAb) pay dividends? If so, how much?
Sequana Medical NV(CHIX:SEQUAb) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers